Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBSE4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $100,895
Award facts
- Contract value 100% obligated
- $100,894.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HEPLISAV-B hepatitis B vaccine (20 mcg/0.5 mL syringes) valued at $100,894.56 under firm fixed price terms. This non-set-aside, competitively awarded contract was executed on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a single delivery order transaction under AmerisourceBergen's larger federal contract vehicle.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through competitive awards and maintains a significant presence in the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBSE4?
SPE2DR26FBSE4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FBSE4 worth?
The government has obligated $100,895 on SPE2DR26FBSE4.
Is contract SPE2DR26FBSE4 an order under another contract?
Yes. SPE2DR26FBSE4 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBSE4 competed?
The extent of competition for SPE2DR26FBSE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award